Drug Name: Joenja
Indications: To treat activated phosphoinositide 3-kinase delta syndrome.
Active Ingredient: Leniolisib
Company: Pharming Intellectual Property B.V.
Approval Date: 3/24/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217759s000lbl.pdf